Mometasone and Markers of Airway Inflammation

• Status: Completed
• Trial end date: 2006-08-01
• Target enrollment: 0
• Participant gender: All

Summary

A post-marketing study to look at the effects of Asmanex on markers of airway inflammation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Creighton University
• Collaborator: Schering-Plough
• Treatments: Mometasone Furoate

Criteria

Inclusion Criteria:

• Asthma

• non-smoker

• FEV1 of at least 60% predicted

Exclusion Criteria:

• Pregnancy or lactation

• Corticosteroid use in past 30 days